Connect with us

Technology

Zimmer Biomet Announces Definitive Agreement to Acquire Paragon 28

Published

on

Demonstrates Zimmer Biomet’s Commitment to Investing in Higher Growth
End-Markets, with Expansion into ~$5 Billion Foot and Ankle Segment

Expected to Enhance Zimmer Biomet’s Financial Profile; Immediately Accretive to Revenue Growth and Accretive to Adjusted EPS within 24 Months of Deal Close

WARSAW, Ind. and ENGLEWOOD, Colo., Jan. 28, 2025 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Paragon 28, Inc. (NYSE: FNA), a leading medical device company focused exclusively on the foot and ankle orthopedic segment, today announced they have entered into a definitive agreement for Zimmer Biomet to acquire all outstanding shares of common stock of Paragon 28 for an upfront payment of $13.00 per share in cash, corresponding to an equity value of approximately $1.1 billion and an enterprise value of approximately $1.2 billion. Paragon 28 shareholders will also receive a non-tradeable contingent value right (CVR) entitling the holder to receive up to $1.00 per share in cash if certain revenue milestones are achieved. The CVR will be payable in whole or in part if net sales exceed $346 million up to $361 million (with the CVR payments calculated linearly between $0.00 and $1.00 if net sales are between $346 million and $361 million) during Zimmer Biomet’s fiscal year 2026. The board of directors of each of Zimmer Biomet and Paragon 28 has unanimously approved the proposed transaction.

Established in 2010, Paragon 28 has an extensive suite of surgical offerings and product systems spanning all major foot and ankle segments, including fracture and trauma, deformity correction and joint replacement. Since its inception, Paragon 28 has been singularly focused on bringing to market innovative solutions to address areas of unmet need in the foot and ankle segment. 

“This proposed transaction further diversifies Zimmer Biomet’s portfolio outside of core orthopedics and positions us well in one of the highest growth specialized segments in musculoskeletal care, while creating cross-selling opportunities in the rapidly growing ASC space,” said Ivan Tornos, President and Chief Executive Officer of Zimmer Biomet. “Paragon 28’s broad and innovative foot and ankle portfolio, robust product pipeline and dedicated and highly trained sales force, combined with Zimmer Biomet’s global reach and capabilities, will uniquely position us to address the unmet patient needs of this highly complex anatomy.”

“We are incredibly proud of the legacy we have built at Paragon 28 as an industry leader committed to continuously improving the outcomes and experiences of patients suffering from foot and ankle conditions,” said Albert DaCosta, Chairman and CEO of Paragon 28. “Joining Zimmer Biomet is an exciting new chapter for Paragon 28 and an incredible opportunity to advance our mission and continue to deliver groundbreaking solutions in the foot and ankle segment.”

Benefits of the Proposed Transaction

Strengthens and expands Zimmer Biomet’s foot and ankle offerings through Paragon 28’s leading technology platform while bolstering existing fracture & trauma and joint replacement portfolios.

Complements Zimmer Biomet’s global footprint and existing infrastructure with Paragon 28’s expansive portfolio, which is expected to drive adoption and accelerate U.S and international growth.

Accelerates Zimmer Biomet’s WAMGR given significant opportunity across a ~$5 billion foot and ankle industry growing high-single digits.

Expedites penetration opportunities in the fast-growing ASC space.

Proposed Transaction Highlights

The proposed transaction is expected to immediately accelerate Zimmer Biomet’s revenue growth. Paragon 28 has announced net revenue for the full year of 2024 to be in a range of $255.9 to $256.2 million, representing 18.2% to 18.4% reported growth over the prior fiscal year. Zimmer Biomet expects the proposed transaction, considering the impact of financing, to be approximately 3% dilutive to adjusted earnings per share in 2025, about 1% dilutive to 2026 adjusted earnings per share and accretive to adjusted earnings per share within 24 months of deal close.

Zimmer Biomet plans to fund the proposed transaction through a combination of cash on the balance sheet and other available debt financing sources. Zimmer Biomet expects to maintain a strong balance sheet and to continue to support its stated capital allocation priorities.

Closing of the proposed transaction is subject to receipt of required regulatory approvals, approval by Paragon 28 stockholders and other customary closing conditions, and is anticipated to close in the first half of 2025. Expected impacts to 2025 financial results will be discussed on Zimmer Biomet’s upcoming fourth quarter 2024 earnings call scheduled for February 6, 2025.

Advisors

Goldman Sachs & Co. LLC is serving as exclusive financial advisor to Zimmer Biomet and Hogan Lovells US LLP is serving as legal advisor.

Piper Sandler & Co. is serving as exclusive financial advisor to Paragon 28 and Cravath, Swaine & Moore LLP is serving as legal advisor.

About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.

With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation. 

For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X/ Twitter at www.twitter.com/zimmerbiomet.

About Paragon 28
Based in Englewood, CO., Paragon 28 is a leading medical device company exclusively focused on the foot and ankle orthopedic segment and is dedicated to improving patient lives. From the onset, Paragon 28 has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, forefoot, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, Charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible. 

Cautionary Statement Regarding Forward-Looking Statements

This release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 regarding Zimmer Biomet and Paragon 28, which involves substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. In some cases, forward-looking statements can be identified by the use of forward-looking terms such as “anticipate,” “estimate,” “believe,” “continue,” “could,” “intend,” “may,” “plan,” “potential,” “predict,” “should,” “will,” “expect,” “are confident that,” “objective,” “projection,” “forecast,” “goal,” “guidance,” “outlook,” “effort,” “target,” “would” or the negative of these terms or other comparable terms. Forward-looking statements in this release include, among other things, statements about the potential benefits of the proposed transaction; anticipated accretion and growth rates; plans, objectives, beliefs, expectations and intentions of the board of directors of Zimmer Biomet, Zimmer Biomet management, the board of directors of Paragon 28 and Paragon 28 management; the financial condition, results of operations and businesses of Zimmer Biomet and Paragon 28; the possibility that the milestone associated with the contingent value rights are achieved in part or at all; and the anticipated timing of closing of the proposed transaction.

These forward-looking statements are based on certain assumptions and analyses made by Zimmer Biomet and Paragon 28 in light of Zimmer Biomet and Paragon 28’s experience and Zimmer Biomet and Paragon 28’s perception of historical trends, current conditions and expected future developments, as well as other factors Zimmer Biomet and Paragon 28 believe are appropriate in the circumstances. These forward-looking statements also are based on the current expectations and beliefs of the respective managements of Zimmer Biomet and Paragon 28 and are subject to certain known and unknown risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Risks and uncertainties include, among other things, (i) risks related to the satisfaction of the conditions to closing the proposed transaction (including the failure to obtain necessary regulatory approvals) in the anticipated timeframe or at all, including uncertainties as whether the stockholders of Paragon 28 will approve the proposed transaction and the possibility that the proposed transaction does not close; (ii) risks related to the possibility that competing offers or acquisition proposals for Paragon 28 will be made; (iii) the occurrence of any event, change or other circumstances that could give rise to the termination of the definitive transaction agreement relating to the proposed transaction, including in circumstances which would require Paragon 28 to pay a termination fee; (iv) risks related to the ability to realize the anticipated benefits of the proposed transaction, including the possibility that the expected benefits from the proposed transaction will not be realized or will not be realized within the expected time period; (v) the risk that the businesses will not be integrated successfully; (vi) risks relating to the achievement, in part or at all, of the revenue milestone necessary for the payment of any contingent value rights; (vii) disruption from the proposed transaction making it more difficult to maintain business and operational relationships, including with customers, vendors, service providers, independent sales representatives, agents or agencies, and Paragon 28’s ability to attract, motivate or retain key executives, employees and other associates; (viii) risk related to the proposed transaction diverting Zimmer Biomet’s and/or Paragon 28’s managements’ attention from the ongoing business operations of their respective business; (ix) negative effects of this announcement or the consummation of the proposed transaction on the market price of Zimmer Biomet and/or Paragon 28’s common stock and on Zimmer Biomet and/or Paragon 28’s operating results; (x) significant transaction costs; (xi) unknown liabilities; (xii) the risk of litigation, including shareholder litigation, and/or regulatory actions, including any conditions, limitations or restrictions placed on approvals by any applicable governmental entities, related to the proposed transaction; and (xiii) (A) other risks and uncertainties discussed in Zimmer Biomet’s and Paragon 28’s respective Annual Reports on Form 10-K or Form 10-K/A, as applicable, for the fiscal year ended December 31, 2023 and their subsequent Quarterly Reports on Form 10-Q (in particular, the risk factors set forth under the headings “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in such Annual Reports and Quarterly Reports), and (B) other risk factors identified from time to time in other filings with the U.S. Securities and Exchange Commission (the “SEC”). Filings with the SEC are available on the SEC’s website at www.sec.gov.

The list of factors that may affect actual results and the accuracy of forward-looking statements is illustrative and is not intended to be exhaustive. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Zimmer Biomet and Paragon 28 undertake no obligation to update any of these forward-looking statements as the result of new information or to reflect events or circumstances after the date of this communication or to reflect actual outcomes, expect as required by law, and expressly disclaim any obligation to revise or update any forward-looking statement to reflect future events or circumstances.

Additional Information about the Proposed Transaction and Where to Find It

In connection with the proposed transaction, Paragon 28 intends to file relevant materials with the SEC, including preliminary and definitive proxy statements relating to the proposed transaction. The definitive proxy statement will be mailed to Paragon 28’s stockholders in connection with the proposed transaction. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND SECURITY HOLDERS OF PARAGON 28 ARE URGED TO READ THE PRELIMINARY AND DEFINITIVE PROXY STATEMENTS AND ALL RELEVANT DOCUMENTS TO BE FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION OR INCORPORATED BY REFERENCE IN THE PROXY STATEMENT WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders may obtain free copies of these documents (if and when they are available) and other related documents filed with the SEC at the SEC’s web site at www.sec.gov, and on Paragon 28’s website at www.paragon28.com. In addition, the proxy statement and other documents may be obtained free of charge by directing a request to Paragon 28, Inc., Robert McCormack, 14445 Grasslands Drive, Englewood, Colorado, telephone: (720) 912-1332.

Participants in the Solicitation

Zimmer Biomet and Paragon 28 and their respective directors and executive officers and other members of management and employees, under SEC rules, may be deemed participants in the solicitation of proxies from the stockholders of Paragon 28 in connection with the proposed transaction. Information regarding Zimmer Biomet’s directors and executive officers can be found in Zimmer Biomet’s definitive proxy statement on Schedule 14A for the 2024 Annual Meeting of Stockholders, filed with the SEC on March 27, 2024 and subsequent statements of beneficial ownership on file with the SEC. Information regarding Paragon 28’s directors and executive officers can be found in Paragon 28’s definitive proxy statement on Schedule 14A for the 2024 Annual Meeting of Stockholders, which was filed with the SEC on April 5, 2024 and subsequent statements of beneficial ownership on file with the SEC. These documents are available free of charge at the SEC’s web site at www.sec.gov, on Zimmer Biomet’s website at www.zimmerbiomet.com and on Paragon 28’s website at www.paragon28.com. Additional information regarding the interest of Paragon 28’s participants in the solicitation of Paragon 28′ stockholders, which may, in some cases, be different than those of Paragon 28’s stockholders generally, will be set forth in the proxy statement related to the proposed transaction described above and other relevant materials to be filed with the SEC if and when they become available.

Zimmer Biomet:

Media
Heather Zoumas-Lubeski
445-248-0577
heather.zoumaslubeski@zimmerbiomet.com

Kirsten Fallon
781-779-5562
kirsten.fallon@zimmerbiomet.com

Investors
David DeMartino
646-531-6115
david.demartino@zimmerbiomet.com

Zach Weiner
908-591-6955
zach.weiner@zimmerbiomet.com

Paragon 28
Media and Investors
Matt Brinckman
720-912-1332
mbrinckman@paragon28.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-announces-definitive-agreement-to-acquire-paragon-28-302362653.html

SOURCE Zimmer Biomet Holdings, Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Keesler Federal Once Again Recognized as Newsweek’s Best Regional Credit Unions

Published

on

By

BILOXI, Miss., Feb. 03, 2025 /PRNewswire/ — For the second year in a row, Keesler Federal Credit Union is being recognized as one of Newsweek’s best regional credit unions.

A recently released study of America’s Best Regional Banks and Credit Unions for 2025 conducted by Newsweek and Plant-A Insights determined the top 500 credit unions and 500 banks in the nation after an examination of 9,170 regional financial institutions across the country. The study considered profitability, financial relevance, risk exposure to financial uncertainties and the general health and stability of each financial institution.

The analysis was further supported by a nationwide examination of more than 845,000 reviews of regional banks and credit unions, 71,000 personal surveys and 1.9 million social media reviews. A rating of one to five stars was then awarded to each institution on the list of the best credit unions and banks.  Keesler Federal was one of only 200 institutions to receive a 5-star rating – the best possible designation.

Plant-A Insights Group which conducted the study produces independent, unbiased company rankings across a variety of industries, categories, and sectors through extensive market research and analytics. The group independently administers all research projects utilizing high standards and transparent research methods.

Andy Swoger, President and CEO of Keesler Federal said the ranking and recognition is gratifying for everyone at Keesler Federal and affirms each team member’s commitment to excellence and extraordinary member service.

“Our outstanding financial performance is a direct result of deliberate and strategic decisions we make to protect our members’ resources and ensure the strength and stability of our credit union,” Swoger said. “And as always, we are committed to delivering first-rate service to our members that goes above and beyond expectations.”

The national recognition comes at an exciting time for Keesler Federal which recently announced its intention to merge with Jefferson Financial Federal Credit Union of Metairie, Louisiana. The merger will add an additional 14 branch locations in the greater New Orleans region and will expand Keesler Federal to 55 total branch locations stretching across Louisiana, Mississippi, and Alabama. The credit union will grow to just under $5 billion and expand to more than 900 employees to serve its membership.

About Keesler Federal Credit Union

Established in 1947, Keesler Federal is a dynamic, stable, financially strong credit union dedicated to building a better community one member, one relationship, and one financial solution at a time. The not-for-profit financial cooperative is owned my its more than 325,000 members worldwide and has 41 locations stretching from New Orleans across the Mississippi Gulf Coast to Mobile. It serves Jackson and Hattiesburg and has four locations in the United Kingdom.  Keesler Federal proudly serves the financial needs of people from all walks of life with membership available to anyone who lives, works, worships, or attends school within the areas it serves. For more information, visit www.kfcu.org.

View original content to download multimedia:https://www.prnewswire.com/news-releases/keesler-federal-once-again-recognized-as-newsweeks-best-regional-credit-unions-302366654.html

SOURCE Keesler Federal Credit Union

Continue Reading

Technology

ScaleFlux Empowers IT Transformation with Consumption-Based Solutions

Published

on

By

As AI adoption drives data center growth, businesses are shifting from capital-intensive infrastructure investments to consumption-based models that align IT spending with actual usage. ScaleFlux’s innovative NVMe SSD solutions empower organizations to reduce costs, improve scalability, and enhance energy efficiency, enabling them to stay competitive while addressing the demands of AI, hybrid cloud, and edge computing environments.

MILPITAS, Calif., Feb. 3, 2025 /PRNewswire-PRWeb/ — The rapid adoption of AI is driving unprecedented growth in the data center industry, with major players like Microsoft, Meta, Google, and Amazon investing $125 billion in AI-focused data centers in 2024 alone, according to a JPMorgan report. (1) These costs, covering electricity, software, and depreciation, highlight a significant gap between industry leaders and smaller companies struggling to compete in this technological revolution. To level the playing field, businesses are shifting away from hefty upfront infrastructure investments and adopting consumption-based pricing models that align IT spending with actual usage. “AI and cloud applications are reshaping industries, but operational efficiency has become non-negotiable,” explains JB Baker, VP of Products at ScaleFlux. “Consumption-based models enable businesses to scale dynamically, gain financial flexibility, and better manage operational costs while optimizing infrastructure for sustainability.”

“Consumption-based models enable businesses to scale dynamically, gain financial flexibility, and better manage operational costs while optimizing infrastructure for sustainability” — JB Baker, VP of Products at ScaleFlux

The Shift from CapEx to OpEx in IT Infrastructure
As businesses adapt to the evolving landscape of AI, cloud, and data-heavy applications, there is a significant shift in IT spending from capital expenditure (CapEx) to operational expenditure (OpEx) models. (2) Adopting consumption-based or lease models allows businesses to scale operations dynamically without the burden of massive upfront investments, making this approach more efficient and financially flexible. (3)

This shift is essential for both enterprises and small and medium-sized businesses looking to adapt to the new IT environment. Aligning IT spending with actual usage optimizes operational costs, enhances scalability, and drives efficiency. As the need for energy-efficient data management intensifies, ScaleFlux’s solutions address the challenges of limited physical space and rising energy costs.

Tackling Rising Energy Demand with Tailored Solutions
This shift also addresses rising energy costs. The global data center industry is experiencing unprecedented growth, with electricity consumption projected to more than double between 2023 and 2028, reaching 857 terawatt-hours (TWh) by 2028. (4) In 2023 alone, data centers accounted for 4.4% of total U.S. electricity consumption, a figure expected to rise to between 6.7% and 12% by 2028. (5)

Consumption-based models align IT spending with actual needs, reducing energy consumption by encouraging right-sizing, enabling dynamic scaling, and promoting the adoption of energy-efficient cloud infrastructure.

Maximizing Efficiency and Profitability with ScaleFlux’s NVMe SSD Solutions
As energy demand rises, consumption-based models are redefining how businesses optimize costs and sustainability. ScaleFlux NVMe SSD solutions empower organizations to reduce operational expenses, improve scalability, and shrink their environmental footprint, helping service providers stay competitive in an evolving market.

Key advantages of ScaleFlux NVMe SSD solutions include:

Energy Efficiency: Significantly reduces power consumption, lowering operational costs and minimizing environmental impact.Higher Density: Allows businesses to store more data in less space, optimizing data center real estate.Scalability: Supports the growing demands of AI, cloud, and data-intensive applications without compromising performance.Cost Optimization: Minimizes cooling and operational costs, maximizing profitability.Performance at Scale: Delivers high-speed performance for demanding workloads like AI and machine learning.

Supporting Hybrid Cloud and Edge Computing Strategies
ScaleFlux’s solutions are pivotal in helping businesses adopt hybrid cloud and edge computing strategies, which are essential for reducing latency, lowering energy costs, and maintaining high performance. Edge computing brings processing power closer to end-users, ensuring real-time application performance, while hybrid cloud environments enable businesses to optimize cost and performance by combining public and private cloud resources.

By 2027, 90% of organizations are expected to deploy hybrid cloud solutions, highlighting the increasing demand for flexible and efficient infrastructure. (6) In this evolving landscape, ScaleFlux’s innovative solutions empower businesses to meet rising digital demands, achieve performance goals, and balance sustainability priorities effectively.

IT Transformation with ScaleFlux Solutions
As the IT industry shifts toward an OpEx-driven economy, ScaleFlux’s innovative storage and memory solutions are helping businesses navigate this transformation. By combining high performance with both financial and energy efficiency, ScaleFlux enables organizations to scale dynamically while meeting sustainability goals.

“As the AI server market expands and industry trends evolve, we are committed to providing solutions that empower businesses to scale in a feasible way,” points out Baker. “While our NVMe SSD solutions ensure businesses can stay ahead of the curve by tackling the challenges of modern IT infrastructure, reducing costs, and minimizing their environmental footprint, we are not stopping there. We also are innovating solutions in the memory domain to streamline the entire data infrastructure.”

About ScaleFlux
In an era where data reigns supreme, ScaleFlux emerges as the vanguard of enterprise storage and memory technology, poised to redefine the landscape of the data infrastructure – from cloud to AI, enterprise, and edge computing. With a commitment to innovation, ScaleFlux introduces a revolutionary approach to storage and memory that seamlessly combines hardware and software, designed to unlock unprecedented performance, efficiency, security and scalability for data-intensive applications. As the world stands on the brink of a data explosion, ScaleFlux’s cutting-edge technology offers a beacon of hope, promising not just to manage the deluge but to transform it into actionable insights and value, heralding a new dawn for businesses and data centers worldwide. For more details, visit https://scaleflux.com/.

References

Nguyen, Britney. “How Many Billions Big Tech Spent on AI Data Centers in 2024.” Yahoo Finance, 30 Dec. 2024, finance.yahoo.com/news/many-billions-big-tech-spent-171500839.html.”Technology Budgets: Moving from Capital Expense (CAPEX) to Operational Expense (OPEX).” CoSN, cosn.org/technology-budgets-moving-from-capital-expense-capex-to-operational-expense-opex-2/.”Demystifying the Cloud Consumption Model.” Deloitte United States, 17 Apr. 2023, deloitte.com/us/en/pages/consulting/articles/cloud-consumption-model.html.”IDC Report Reveals AI-Driven Growth in Datacenter Energy Consumption, Predicts Surge in Datacenter Facility Spending amid Rising Electricity Costs.” IDC, 24 Sept. 2024, idc.com/getdoc.jsp?containerId=prUS52611224.Moss, Sebastian. “Doe: Data Centers Consumed 4.4% of US Power in 2023, Could Hit 12% by 2028.” All Content RSS, 20 Dec. 2024, datacenterdynamics.com/en/news/doe-data-centers-consumed-44-of-us-power-in-2023-could-hit-12-by-2028/.Ashare, Matt. “Global Cloud Spend to Surpass $700B in 2025 as Hybrid Adoption Spreads: Gartner.” CIO Dive, 19 Nov. 2024, ciodive.com/news/cloud-spend-growth-forecast-2025-gartner/733401/.

Media Inquiries:
Karla Jo Helms
JOTO PR™
727-777-429
jotopr.com

Media Contact

Karla Jo Helms, JOTO PR™, 727-777-4629, khelms@jotopr.com, jotopr.com

View original content to download multimedia:https://www.prweb.com/releases/scaleflux-empowers-it-transformation-with-consumption-based-solutions-302366605.html

SOURCE JOTO PR™

Continue Reading

Technology

Infotel Releases New Whitepaper Addressing the Difficulties of Managing Data Security, Consumer Privacy, and AI Governance in Large Enterprises

Published

on

By

TAMPA, Fla., Feb. 3, 2025 /PRNewswire/ — Infotel Corp., a global leader in enterprise software solutions, today announced the release of a comprehensive whitepaper addressing the critical challenges organizations face in managing data governance, risk, and compliance (GRC) in an increasingly complex regulatory landscape.

The whitepaper, Managing Governance, Risk, and Compliance in the Wild West of Converging Data Security and Consumer Privacy Policy, introduces the concept of the Data Governance Trifecta, where compliance mandates for data security, consumer privacy, and generative AI converge. This convergence often creates data management challenges for large organizations as they grapple with siloed teams attempting to manage compliance for tens of thousands of employees, customers and partners across their enterprises.

“Organizations today face unprecedented challenges in managing risk in their data centers,” said Arnaud Siminski, Software Division Director at Infotel. “With the average cost of a data breach at about $5 million, and 68% of breaches involving human error, it’s clear that traditional approaches are no longer sufficient. This whitepaper offers a practical framework for building what we call the ‘Compliance Alliance,’ ­­­ a collaborative approach that transforms governance challenges into opportunities for innovation and competitive advantage.”

The Whitepaper Provides Actionable Strategies for:

Breaking down organizational silos that lead to mismanaged data

Understanding and implementing emerging AI governance frameworks

Managing Shadow Data risk

Building cross-departmental collaboration for enhanced compliance

Developing robust data governance frameworks

For the C-level executive, Infotel has released an executive summary detailing implementation strategies for data protection officers, privacy leaders, and business unit managers. You can access the full whitepaper or the executive summary from the Infotel website.

About Infotel

Infotel provides innovative enterprise software and consulting solutions to help organizations optimize data performance, enhance security, and achieve compliance. From database management to GDPR compliance and long-term archiving, Infotel delivers cutting-edge tools that unlock the full potential of data.

To learn more about Infotel’s enterprise technology solutions and 40-year history of innovation in the U.S., visit infotel-software.com or contact us at software@infotel.com.

Summary:

Infotel Releases Whitepaper on Data Security, Privacy, and AI Governance Challenges

Infotel has released a whitepaper, Managing Governance, Risk, and Compliance in the Wild West of Converging Data Security and Consumer Privacy Policy, offering essential strategies for navigating data governance, risk, and compliance challenges. The resource addresses the growing complexity of data security, consumer privacy, and generative AI governance, highlighting key risks such as shadow data and human error. The whitepaper provides actionable insights, including a seven-point action plan and strategies to foster cross-departmental collaboration.

View original content to download multimedia:https://www.prnewswire.com/news-releases/infotel-releases-new-whitepaper-addressing-the-difficulties-of-managing-data-security-consumer-privacy-and-ai-governance-in-large-enterprises-302366664.html

SOURCE Infotel Corp

Continue Reading

Trending